[F:1][C:2]([F:18])([F:17])[C:3]1[CH:8]=[CH:7][C:6]([NH:9][C@@H:10]([C:14]([OH:16])=O)[CH:11]([CH3:13])[CH3:12])=[CH:5][CH:4]=1.[CH2:19]([NH2:27])[CH2:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1.Cl.C(N=C=NCCCN(C)C)C.[OH2:40].[OH:41]N1C2C=CC=CC=2N=N1>C(Cl)Cl>[F:1][C:2]([F:18])([F:17])[C:3]([OH:41])=[O:40].[C:21]1([CH2:20][CH2:19][NH:27][C:14](=[O:16])[C@@H:10]([CH:11]([CH3:12])[CH3:13])[NH:9][C:6]2[CH:5]=[CH:4][C:3]([C:2]([F:1])([F:18])[F:17])=[CH:8][CH:7]=2)[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1N-[4-(Trifluoromethyl)phenyl]-D-valine (20 mg, 0.077 mmol) obtained in step 1, phenethylamine (11 μl, 0.087 mmol), 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (18 mg, 0.12 mmol) and 1-hydroxybenzotriazole monohydrate (22 mg, 0.12 mmol) were mixed in methylene chloride (3 mL), and the mixture was stirred overnight at room temperature. The solvent was evaporated and, using the following purification step A, the title compound (8.48 mg, 0.018 mmol, 23%) was obtained.